Table 1.
The distribution of the different group B genotypes at Kilifi during the 11 consecutive epidemics of the surveillance
| Peak epidemic month | Total group B strains identified | No. group B sequenced (%)a | Genotypes identified among the sequenced group B strains | ||
|---|---|---|---|---|---|
| SAB1 | BA (%)b | New type | |||
| May 2002 | 1 | 1 (100·0) | 1 | 0 (0) | 0 |
| Jan 2003 | 33 | 27 (81·8) | 25 | 2 (7·4) | 0 |
| Apr 2004 | 18 | 13 (72·2) | 12 | 1 (8·3) | 0 |
| Jan 2005 | 117 | 111 (94·9) | 3 | 108 (97·3) | 0 |
| Mar 2006 | 9 | 9 (100·0) | 0 | 9 (100) | 0 |
| Jan 2007 | 22 | 19 (86·2) | 0 | 19 (100) | 0 |
| Jan 2008 | 158 | 140 (88·6) | 0 | 140 (100) | 0 |
| Feb 2009 | 29 | 14 (48·2) | 0 | 14 (100) | 0 |
| Mar 2010 | 81 | 60 (74·1) | 0 | 60 (100) | 0 |
| Feb 2011 | 16 | 15 (93·8) | 0 | 15 (100) | 0 |
| Mar 2012 | 90 | 79 (87·8) | 0 | 76 (96·2) | 3 |
| Total | 574 | 488 (85·0) | 41 | 444 (91·0) | 3 |
a
Numbers in brackets represent the proportion of group B RSV‐positive samples that were sequenced of all those that were identified and subtyped as group B.
b
Numbers in brackets represent percentage of the sequenced group B genotypes that genotyped into BA.
Peak epidemic month given by the three letter month abbreviation.